Itavastatin and resveratrol increase triosephosphate isomerase protein in a newly identified variant of TPI deficiency is a research paper published in Disease Models & Mechanisms (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21 AG059385
National Institutes of Health
Grant: T32 GM133332
National Institutes of Health
Grant: R01 HD104346
National Institutes of Health
Grant: R01 HD105311
National Institutes of Health
Grant: R01 GM103369
National Institutes of Health
Grant: 5R01GM103369-03
Protein quality control mechanisms of novel soluble substrates
National Institutes of Health
Grant: 1T32GM133332-01A1
Predoctoral Training in Pharmacological Sciences (Resubmission)
National Institutes of Health
Grant: 1R21AG059385-01A1
Regulators of cytosolic protein quality control in aging and disease
National Institutes of Health
Grant: 5R01HD104346-03
High-content screening for TPI Deficiency therapeutics
National Institutes of Health
Grant: 5R01HD105311-02
Developing the first TPI Df therapeutics
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals